Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms [Phase 1]
Phase 1 clinical trial from Mayo Clinic evaluating the cognitive effects of lorazepam in healthy older adults with TOMM40 polymorphisms, in …
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia [Phase 4]
Phase 4 trial evaluating tolerability of rivastigmine when switching from the oral formulation to a transdermal patch in Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR) [Phase 1]
A Phase 1 clinical trial evaluating an extended-release formulation of rosiglitazone (RSG XR) in mild Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 study evaluated RO5313534 as an add-on to donepezil in patients with mild to moderate Alzheimer's disease; the trial has completed…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease. [Phase 1]
Phase 1 multiple ascending dose study of R1450 in patients with Alzheimer's disease has completed. The trial evaluated safety, tolerability,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers [Phase 1]
This document provides an update on a Phase 1 study of RO4602522 in patients with Alzheimer's disease and in healthy volunteers, noting its …
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET) [Phase 2]
Phase 2 bridging study of Pittsburgh Compound B and 18F-flutemetamol brain PET imaging in Alzheimer's disease; results posted.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
Completed clinical trial update reporting functional MRI findings in brain regions vulnerable to Alzheimer's disease in individuals at risk.
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) [Phase 3]
Phase 3 Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) has completed; it evaluated naproxen and celecoxib for preventing Alz…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation [Phase 1]
Phase 1 relative bioavailability study in healthy subjects evaluating the pharmacokinetics of HTL0009936 after a single dose of the prototyp…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease [Phase 2]
A single-site, randomized, double-blind, placebo-controlled Phase 2 trial of NIC5-15 in Alzheimer's disease completed.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease [NA]
This clinical trial update assesses the safety and efficacy of long-term treatment with the PINS Stimulator System in patients with Alzheime…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Cytokines and Cognitive Decline in Alzheimer's Disease [NA]
Completed clinical trial sponsored by Poitiers University Hospital investigating the role of cytokines in cognitive decline in Alzheimer's d…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil [Phase 3]
Phase 3 safety and efficacy study evaluating Dimebon (latrepirdine) in patients with mild-to-moderate Alzheimer's disease on donepezil has c…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease [Phase 3]
Phase 3 safety and efficacy trial of Dimebon (latrepirdine) in moderate-to-severe Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease [Phase 3]
A Phase 3 study evaluating the safety and efficacy of oral dimebon (latrepirdine) in patients with mild-to-moderate Alzheimer's disease has …
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: An Extension of the CONCERT Protocol (DIM18) [Phase 3]
Notes termination of the DIM18 extension of the CONCERT protocol in a Phase 3 trial for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits
The document reports the completion of a study validating the use of telehealth in clinical drug development for subjects with mild cognitiv…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Alzheimer's Disease - Input of Vitamin D With mEmantine Assay [Phase 3]
A Phase 3 clinical trial evaluating the addition of Vitamin D to memantine for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Gait and Alzheimer Interaction Tracking (GAIT) Study
The GAIT study conducted at University Hospital Angers has completed, focusing on gait apraxia in the context of Alzheimer’s disease and rel…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease [NA]
A completed clinical trial evaluated whether singing sessions can alleviate physical and moral pain in people with Alzheimer's disease. The …
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program [NA]
A completed clinical trial evaluating Distance Savvy, a distance education program for dementia family caregivers (Tele-Savvy). Emory Univer…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Overuse of Antidepressant in Patients With Alzheimer Disease
A completed clinical trial investigating the overuse of antidepressants in patients with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: The Effect of Repeated Transcranial Magnetic Stimulation on Off-line Resting Electroencephalographic Signal in Alzheimer's Disease [NA]
The clinical trial evaluating the effect of repeated transcranial magnetic stimulation on off-line resting EEG in Alzheimer's disease has be…
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Long-Term Study of IGIV, 10% in Alzheimer´s Disease [Phase 3]
Phase 3 long-term study of 10% intravenous immunoglobulin (IGIV) in Alzheimer's disease was terminated; results posted in 2016.